Impairment of kynurenine metabolism in cardiovascular disease.
Rudzite
V
V
Latvian Research Institute of Cardiology, Riga, USSR.
Sileniece
G
G
Liepina
D
D
Dalmane
A
A
Zirne
R
R
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D009202:Cardiomyopathies / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D002478:Cells, Cultured; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism*; D007538:Isoniazid / Q000633:toxicity; D007737:Kynurenine / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D009525:Niacin / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D014364:Tryptophan; D014661:Vasoconstriction / Q000502:physiology; D026681:Vitamin B 6 Deficiency / Q000139:chemically induced / Q000150:complications / Q000378:metabolism*; D014883:Water-Electrolyte Imbalance / Q000209:etiology / Q000378:metabolism
D000959:Antihypertensive Agents; D009525:Niacin; D007737:Kynurenine; D014364:Tryptophan; D007538:Isoniazid